title: Simply Science: Will American science rise from the ashes?
author: The Economist
content_type: newsletter
publication: e.economist.com
published: 2026-02-18T13:17:52-06:00
source_url: gmail://19c7230129e266d0
word_count: 1304
Also: ICE’s new software tools could speed up deportations
February 18th 2026 For subscribers
Simply Science
Illuminating insights, delivered weekly
Will American science rise from the ashes?
Geoffrey Carr
Senior editor
Phoenixes die in flames, but are then reborn. So the location of this year’s meeting of the American Association for the Advancement of Science (AAAS) struck me, on arrival, as a poignant, if unintended, piece of symbolism. Phoenix, Arizona had never before hosted the AAAS. It has done so now at a moment when many in the country’s scientific establishment fear their field is, indeed, undergoing immolation. What will emerge from the flames remains to be seen.
Viewed historically, America’s science establishment—a web of national laboratories, top-flight universities and government agencies such as NASA—is an extraordinary thing. Nothing like it has existed in the past and attempts by others (even including the Soviet Union during the Cold War) to emulate it have so far produced but pale imitations, though China is catching up fast. And it was no happenstance. It was a deliberate creation, inspired by the appliance of science to everything from radar to nuclear weapons that helped America and its allies win the second world war. The intention was both to continue this success and to extend it into the civilian economy.
For the scientists tasked with this mission the deal was, as one of the meeting’s speakers put it, “Give us the money and leave us alone, and we’ll give you the goods.” A sweet bargain which perhaps bred complacency. For, though science certainly did deliver the goods, there was anguished hand-wringing by participants in the meeting that its practitioners have lost touch with the people, and in doing so have lost their trust, as well. It was not so much that voters had chosen an administration which seems indifferent to much of science and actively hostile to the rest. That was a side-effect of Donald Trump’s election, not the reason for it. It was that when this abundant source of the country’s strength and prosperity was assaulted, most people seemed to shrug their shoulders.
Sudip Parikh, CEO of the AAAS, certainly recognises this, and that things will never be the same again. Quoting Mark Carney, he told me, “This is a rupture, not a transition.” But he says that it brings an opportunity to think about priorities, and to try to engage more with the people—who are, after all, supposed to be science’s beneficiaries. The one piece of good news is that, nine days before the meeting began, America’s Congress pushed back against the administration’s actions by rejecting $30bn of proposed cuts to the science budget. But even though Congressfolk also tried to tighten instructions about how the money is spent, Dr Parikh worries how that will work in practice. It does, though, show bipartisan political support for the country’s scientists and suggests that, though what rises from the ashes will surely have different plumage, it could still be a spectacular bird.
Meanwhile, along with the hand-wringing, the meeting still managed to put on some interesting sessions. I have reported on two of these. One is the emerging subject of exposomics, which some see as just a grandiose name for environmental health and others as an interesting new approach to understanding how the interaction between nature and nurture causes disease. The second is the use of crystals called perovskites to make the elements of neuromorphic computing, which attempts to mimic how brains work.
As always, please send any thoughts or questions to sciencenewsletter@economist.com.
Editor’s picks
The best of our science coverage
The nature of nurture
The Human Exposome Project will map how environmental factors shape health
It makes the Human Genome Project look easy
Time to shine
Brain-like computers could be built out of perovskites
The long-hyped materials may have found their niche
Frontier AI
How ICE’s new software tools could speed up deportations
The risk of overreach is high
Podcast
Babbage
How to think like a chess pro
Listen
Our Well Informed column
Can the shingles vaccine slow ageing?
The evidence is surprisingly strong
Dementia is tragically common among the elderly. In 2021 57m people worldwide were thought to have the condition. Ageing is a risk factor for many other ailments too, ranging from chronic inflammation to a decline in organ function. A growing body of work, however, suggests that simply taking a course of the shingles vaccine can meaningfully slow the decline. The new data, from a range of countries, suggests that it cuts risk by 20%.
Read the full article →
Picture of the week
Image: National Environmental Satellite, Data, and Information Service
A recent blast of Arctic air created what are known as cloud streets over the waters of the Gulf and Atlantic. These long, parallel bands of clouds, also called horizontal convective rolls, can develop when cold, dry air flows over relatively warmer water.
What our science journalists are reading
▸| These tubes could harvest ocean energy (_New York Times_)
▸| Why we can’t focus when we’re tired (_Wall Street Journal_)
▸| Astronomers are puzzling over a planetary system (Reuters)
▸| What does ageing mean for autistic people’s health? (_Nature_)
Download our app for iOS and Android
This email has been sent to spence.burleigh@gmail.com because you signed up for this newsletter or because it is included in your subscription.
Registered in England and Wales. No. 236383.
The Adelphi, 1-11 John Adam Street, London, WC2N 6HT
View email online Privacy Policy Terms & Conditions
Copyright © The Economist Newspaper Limited 2026. All rights reserved.
This email was sent to: spence.burleigh@gmail.com
This email was sent by: The Economist Newspaper Ltd., The Adelphi, 1-11 John Adam Street, London, London, WC2N 6HT, GB